Wafra Inc. Biogen Inc. Transaction History

Wafra Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $9.74 Million - $10.7 Million	-44,430 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $8.18 Million - $12.8 Million	-37,745 Reduced 45.93%	44,430 $10.5 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $9.67 Million - $12.2 Million	34,724 Added 73.18%	82,175 $24.7 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $13.9 Million - $18.2 Million	47,451 New	47,451 $16.8 Million

993

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.